Recent Updates
Recently added Catalysts
OCGN

Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2

Wednesday, October 12, 2022 1 min read
Key Takeaway: Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2

Full Press Release Details

Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2.
Tags: OCGN Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Oct 12, 2022